Highlights from the 22nd International Vasculitis Conference, Melbourne, Australia

Published on March 6, 2026
Highlights from the 22nd International Vasculitis Conference, Melbourne, Australia

The recent vasculitis conference delivered important advances in classification, pathogenesis, therapeutics, and precision medicine in ANCA-associated vasculitis (AAV) and related glomerular diseases. Below is a synthesis of key developments relevant to ISGD members.

Continue reading on website
Other news

Prediabetes in Children and Adults with Glomerular Disease

March 3, 2026
AbstractIntroduction: Glomerular disease (GD) and diabetic nephropathy are both leading causes of end-stage kidney disease (ESKD) in the USA. Much is known about each individually, but less of any interactions between the two. There is emerging evidence that factors specific to GD, such as immunosuppression, may increase the risk of diabetes, which in turn could compound glomerular filtration rate

Contactin-1-Associated Membranous Nephropathy after Multiple mRNA 1273 COVID-19 Vaccinations: A Case Report

March 9, 2026
AbstractContactin-1-associated membranous nephropathy is a rare type of membranous nephropathy typically seen in the setting of chronic inflammatory demyelinating polyneuropathy. Here we present a case of a 79-year-old man who presented with ankle edema and was found to have 2,888 milligrams of proteinuria per 24 h and membranous nephropathy on kidney biopsy. Staining for multiple membranous antig